Sponsor Pipeline

Nanjing Yoko Biomedical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07634198 A Clinical Study of YK-1169 Versus Ceftazidime-Avibactam in Adults With Hospital-Acquired… Hospital-acquired Bacterial Pneumonia (HABP) Not Yet Recruiting
Get alerts when Nanjing Yoko Biomedical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free